[Alpha Networks] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for New Directors and Representatives

1. Date of Shareholders' Meeting Resolution: 2026/05/26 2. Names and Titles of Directors Permitted to Engage in Competitive Activities: (1) Corporate Director: Qisda Corporation (2) Corporate Director Representative: Huang Wen-fang (3) Corporate Director Representative: Chen Chi-hung (4) Corporate Director Representative: Huang Han-chou (5) Corporate Director Representative: Hung Chiu-chin (6) Independent Director: Li Shu-hsing (7) Independent Director: Hsieh Ming-te (8) Independent Director: Chiang Cheng-jung (9) Independent Director: Chen Chung-jui 3. Scope of Permitted Competitive Activities: Includes various roles in Qisda Corporation, DFI Inc., AUO Corporation, BenQ Hospitals, and other affiliated entities. 4. Duration of Permission: During the tenure as a director or representative of the Company. 5. Resolution Status: Passed as proposed in accordance with Article 209 of the Company Act. 6. Competitive Activities in Mainland China: Involves Qisda Corporation and its representatives (Chen Chi-hung, Huang Han-chou, Hung Chiu-chin) in medical, investment, and manufacturing sectors. 7. Names and Titles in Mainland China: Chairman or Corporate Representative at BenQ Biotech (Shanghai), Nanjing BenQ Hospital, Suzhou BenQ Hospital, etc. 8. Locations in Mainland China: Shanghai, Nanjing, and Suzhou. 9. Business Scope in Mainland China: Medical device manufacturing, management consulting, medical services, investment holding, and material R&D. 10. Impact on Financials/Operations: None. 11. Investment Amount/Shareholding: None. 12. Other: None.